Valuation: Faes Farma, S.A.

Market Cap 1.5B 1.68B 1.38B 1.25B 2.34B 159B 2.39B 16.48B 6.62B 83.81B 6.3B 6.16B 264B P/E 2026 *
18.1x
P/E 2027 * 14x
Enterprise Value 1.79B 1.99B 1.64B 1.49B 2.78B 189B 2.83B 19.59B 7.87B 99.62B 7.49B 7.33B 314B EV / Sales 2026 *
2.43x
EV / Sales 2027 * 2.21x
Free-Float
78.08%
Yield 2026 *
2.76%
Yield 2027 * 3.37%
1 day+1.05%
1 week+4.10%
1 month+3.43%
3 months+5.81%
6 months-0.62%
Current year-6.49%
1 week 4.62
Extreme 4.62
4.88
1 month 4.52
Extreme 4.52
5.03
Current year 4.32
Extreme 4.315
5.44
1 year 4.32
Extreme 4.315
5.44
3 years 2.91
Extreme 2.91
5.44
5 years 2.86
Extreme 2.865
5.44
10 years 2.57
Extreme 2.57
5.48
Manager TitleAgeSince
Chief Executive Officer - 01/09/2024
Director of Finance/CFO - 14/07/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman - 16/05/1991
Director/Board Member - 02/08/2010
Director/Board Member - 19/06/2019
Date Insider Type Main position Quantity % Market Cap. Importance
2/4/26 A Others

Director

53,900 0.0170%
2/4/26 A Others

Director

87,383 0.0276%
2/4/26 A Sell

Director

24,000 0.0076%
Change 5-day change 1-year change 3-year change Capi.($)
+1.05%+4.10%+8.18%+62.73% 1.68B
+3.19%+11.31%+64.28%+155.91% 1,263B
-0.73%+3.56%+44.65%+84.17% 658B
+1.41%+3.24%+35.25%+108.88% 521B
+0.42%+3.20%+55.81%+72.50% 391B
+2.18%+2.93%+73.90%+45.59% 369B
+1.12%+4.52%+34.76%+58.24% 307B
+6.96%+8.86%+11.95%+36.20% 290B
+1.15%+6.09%+56.15%+82.25% 252B
+3.06%+9.38%+42.48%+117.32% 212B
Average +1.98%+5.72%+42.74%+82.38% 426.36B
Weighted average by Cap. +2.01%+6.60%+50.49%+100.42%

Financials

2026 *2027 *
Net sales 734M 820M 675M 612M 1.14B 77.85B 1.17B 8.06B 3.23B 40.95B 3.08B 3.01B 129B 793M 885M 729M 661M 1.24B 84.07B 1.26B 8.7B 3.49B 44.22B 3.32B 3.25B 139B
Net income 84.03M 93.83M 77.3M 70.04M 131M 8.91B 133M 922M 370M 4.69B 352M 345M 14.78B 109M 121M 100M 90.64M 169M 11.53B 173M 1.19B 479M 6.06B 456M 446M 19.13B
Net Debt 284M 317M 261M 236M 442M 30.06B 450M 3.11B 1.25B 15.81B 1.19B 1.16B 49.86B 246M 275M 226M 205M 383M 26.08B 390M 2.7B 1.08B 13.72B 1.03B 1.01B 43.27B
Projected Income Statement - Annual - Faes Farma, S.A.
Logo Faes Farma, S.A.
Faes Farma SA is a Spain-based company engaged in the pharmaceutical industry. The Company specializes in the research, production, distribution and sale of prescription and generic drugs, over-the-counter (OTC) medicines, food supplements and personal care treatments, as well as raw materials for the pharmaceutical use. The Company’s research lines are mainly focused on the development of new drugs for the treatment of allergy, venous insufficiency and irritable bowel syndrome, among others. In addition, it provides animal nutrition products. The Company operates in Spain, Portugal, Chile and Mexico, among others. It controls a number of subsidiaries, such as Laboratorios Vitoria SA, Laboratorios Veris SA, Lazlo International SA, Ingaso Farm SLU, Esfion SA and Biotecnet I MAS D SA.
Employees
2,611
Date Price Change Volume
30/10/26 €4.825 +1.05% 317,015
29/10/26 €4.775 +0.74% 197,893
28/10/26 €4.740 -.--% 149,494
27/10/26 €4.740 +1.17% 107,631
26/10/26 €4.685 +1.08% 107,069
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Faes Farma, S.A.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
4.825EUR
Average target price
5.430EUR
Spread / Average Target
+12.54%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Faes Farma, S.A.